WRLD A.LIVE

23:001 report

• Type 2 Diabetes with Celiac Disease Shows Higher Complication Risk European Medical Journal

22:00nothing heard

21:00nothing heard

20:00nothing heard

19:00nothing heard

18:00nothing heard

17:00nothing heard

16:00nothing heard

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:003 reports

• fda approved weight loss drugs for diabetes BusinessWorld Online
• ozempic diabetes drug for weight loss BusinessWorld Online
• Molecular regulator CA8 may offer new therapeutic target for type 2 diabetes News-Medical

09:003 reports

• new diabetes drug for weight loss BusinessWorld Online
• Will the FDA Approve Retatrutide? NEXT.io
• Experimental Add-On Drug Boosted Weight Loss In Diabetes Patients On Dulaglutide Dr. Axe

08:00nothing heard

07:001 report

• Association of the Fibrosis-4 Index With Indices of Atherosclerosis in Patients With Type 2 Diabetes Mellitus The Cureus Journal of Medical Science

06:00nothing heard

05:005 reports

• lilly oral weight loss drug BusinessWorld Online
• Retatrutide: Separating the Science from the Hype nerdbot
• A New, Stronger GLP-1 Is Currently in Clinical Trials. Here's What Researchers Want You to Know Women's Health
• Promising new weight-loss drugs The Star
• Retatrutide and Survodutide Make Inroads Into Weight Loss for Diabetic Patients TCTMD.com

04:00nothing heard

03:002 reports

• FDA Authorizes First Continuous Ketone Monitor for Diabetes JAMA
• signaling to coordinate insulin secretion and hepatic glucose production Science | AAAS

02:00nothing heard

01:001 report

• The role of primary care physicians in shaping diabetic foot knowledge and health-seeking behavior: a cross-sectional analysis Nature

00:002 reports

• Continuous glucose monitors sustain lower blood sugar and reduce risk for chronic kidney disease in people with type 2 diabetes Kaiser Permanente Division of Research
• The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications Pharmacy Times